Cromos™ Pharma has published a white paper on the new EU clinical trial regulation (no. 536/2014) and investigator-led studies

We are glad to share with you our new white paper by Cromos™ Pharma’s VP, International Business & Operations Dr. Gearóid Tuohy regarding a new Clinical Trial Regulation (Regulation [EU] No 536/2014), scheduled for application this year, and its potential impact on the current imbalances in clinical trials.

Please follow the link link to the whitepaper that provides the detailed insight into this issue.



To arrange an introductory meeting and find out how our experience can benefit your next clinical project.